Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 27,198 | 19,094 | 16,311 | 9,965 | 22,199 |
| Operating Income | -27,198 | -19,094 | -16,311 | -9,965 | -22,199 |
| Interest Expense | 1,586 | 623 | 401 | 740 | 293 |
| Other Income | 3,744 | 5,532 | 2,069 | 2,208 | 5,922 |
| Pre-tax Income | -25,040 | -14,185 | -14,643 | -8,497 | -16,570 |
| Income Tax | 754 | -53 | 44 | 310 | 173 |
| Net Income Continuous | -25,794 | -14,132 | -14,687 | -8,807 | -16,743 |
| Net Income | $-25,794 | $-14,132 | $-14,687 | $-8,807 | $-16,743 |
| EPS Basic Total Ops | -0.32 | -0.42 | -0.16 | -0.08 | -0.03 |
| EPS Basic Continuous Ops | -0.32 | -0.18 | -0.18 | -0.11 | -0.22 |
| EPS Diluted Total Ops | -0.32 | -0.42 | -0.16 | -0.08 | -0.03 |
| EPS Diluted Continuous Ops | -0.32 | -0.18 | -0.18 | -0.11 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.16 | -0.18 | N/A | N/A |
| EBITDA(a) | $-26,853 | $-18,873 | $-16,053 | $-9,808 | $-22,042 |